Literature DB >> 181971

The macrophage as a secretory cell in chronic inflammation.

P Davies, A C Allison.   

Abstract

Although it is clear that macrophages are always present at sites of chronic inflammation their contribution to the evolution of these lesions is not well understood. In vitro studies have shown that macrophages secrete a variety of products on exposure to different stimuli. These include hydrolytic enzymes, active at acid or neutral pH, with known capacity for degrading tissue constituents. Lysosomal acid hydrolases are released from viable cells over a prolonged period of time by various agents known to cause, or are associated with, chronic inflammation. These agents may be nonimmunogenic substances, such as carrageenan and asbestos, which interact directly with macrophages or alternatively the products of immune reactions involving either B or T lymphocytes. These lymphocyte products include immune complexes of certain composition and the secreted products of T lymphocytes stimulated by nonspecific mitogens or specific antigens. In marked contrast biologically inactive substances such as latex particles or digestible substrates such as erythrocytes do not induce the selective release of acid hydrolases from macrophages. It is clear that alghough macrophages secrete abundant amounts of neutral proteinases under certain conditions this release does not occur necessarily during the release of acid hydrolases induced by inflammatory agents. The role played by acid and neutral hydrolases secreted by macrophages during the various stages of chronic inflammatory responses remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181971     DOI: 10.1007/bf01972187

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  67 in total

1.  Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro.

Authors:  D D Wood; S L Gaul
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

Review 2.  Lysosomes and the toxicity of particulate pollutants.

Authors:  A C Allison
Journal:  Arch Intern Med       Date:  1971-07

3.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  Normal macrophage migration inhibition in dexamethasone-treated guinea-pigs.

Authors:  M D Lockshin
Journal:  Experientia       Date:  1972-05-15

5.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

Review 6.  Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae.

Authors:  I Ginsburg
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

7.  Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.

Authors:  S Gordon; J C Unkeless; Z A Cohn
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

8.  The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues.

Authors:  T D Cooke; E R Hurd; M Ziff; H E Jasin
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

9.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  In vitro induction of lysosomal enzymes by phagocytosis.

Authors:  S G Axline; Z A Cohn
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Lysosomal enzymes of phagocytes and the mechanism of their release.

Authors:  M Ferencík; J Stefanovic
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

2.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

Review 3.  Macrophage proteases and rheumatic diseases: regulation of plasminogen activator by thymus-derived lymphocytes.

Authors:  S Gordon; W Newman; B Bloom
Journal:  Agents Actions       Date:  1978-01

4.  The effects of different particulate stimuli on the extracellular release of prostaglandins and lysosomal enzymes from mouse peritoneal macrophages in vitro [proceedings].

Authors:  N Skeldon; L Steele
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

5.  Inhibitory effect of pregnancy on the migration of the inflammatory cells: a quantitative histological study.

Authors:  R Senelar; J P Bureau
Journal:  Br J Exp Pathol       Date:  1979-06

6.  Comparative studies of erythrophagocytosis in the rabbit and human vitreous.

Authors:  J V Forrester; I Grierson; W R Lee
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-11-08

7.  Perifused alveolar macrophages. A technique to study the effects of toxicants on prostaglandin release.

Authors:  P Sirois; A Cadieux; M Rola-Pleszcynski; R Bégin
Journal:  Experientia       Date:  1982-09-15

8.  Sodium aurothiomalate does not block interleukin 1 production in rabbits.

Authors:  Y Zurovsky; H P Laburn; D Mitchell; A Ruck
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

9.  Smooth muscle cell proliferation in the occluded rat carotid artery: lack of requirement for luminal platelets.

Authors:  J R Guyton; M J Karnovsky
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

10.  Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.

Authors:  Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.